EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)
K-Number: K241923 · 2024-12-06
Device Summary
Frequently Asked Questions
What is the EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)?
EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100) is a medical device that received FDA 510(k) clearance on 2024-12-06. The listed applicant is Ever Fortune.Ai, Co., Ltd.. The 510(k) number is K241923.
When did EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100) receive FDA 510(k) clearance?
EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100) received FDA 510(k) clearance on 2024-12-06, under 510(k) number K241923.
Who is the listed applicant for EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)?
The FDA 510(k) record lists Ever Fortune.Ai, Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)?
The FDA product code for EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100) is QAS.
Other records listing Ever Fortune.Ai, Co., Ltd. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: QAS)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.